SE7702251L - Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol - Google Patents
Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanolInfo
- Publication number
- SE7702251L SE7702251L SE7702251A SE7702251A SE7702251L SE 7702251 L SE7702251 L SE 7702251L SE 7702251 A SE7702251 A SE 7702251A SE 7702251 A SE7702251 A SE 7702251A SE 7702251 L SE7702251 L SE 7702251L
- Authority
- SE
- Sweden
- Prior art keywords
- dichlorophenoxy
- butylamino
- propanol
- tert
- preparing
- Prior art date
Links
- XYCMOTOFHFTUIU-UHFFFAOYSA-N cloranolol Chemical compound CC(C)(C)NCC(O)COC1=CC(Cl)=CC=C1Cl XYCMOTOFHFTUIU-UHFFFAOYSA-N 0.000 title 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 208000001871 Tachycardia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000006794 tachycardia Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76GO00001331A HU172137B (hu) | 1976-03-02 | 1976-03-02 | Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7702251L true SE7702251L (sv) | 1977-09-03 |
| SE440647B SE440647B (sv) | 1985-08-12 |
Family
ID=10996805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7702251A SE440647B (sv) | 1976-03-02 | 1977-03-01 | Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4310549A (sv) |
| JP (1) | JPS5923299B2 (sv) |
| AT (1) | AT348507B (sv) |
| AU (1) | AU508766B2 (sv) |
| BE (1) | BE851938A (sv) |
| CA (1) | CA1091254A (sv) |
| CH (1) | CH627732A5 (sv) |
| CS (1) | CS190340B2 (sv) |
| DD (1) | DD128610A5 (sv) |
| DE (1) | DE2709109C3 (sv) |
| DK (1) | DK143554C (sv) |
| FI (1) | FI65231C (sv) |
| FR (1) | FR2342956A1 (sv) |
| GB (1) | GB1573191A (sv) |
| HU (1) | HU172137B (sv) |
| IL (1) | IL51574A (sv) |
| IN (1) | IN144243B (sv) |
| KE (1) | KE3340A (sv) |
| MY (1) | MY8500104A (sv) |
| NL (1) | NL7702170A (sv) |
| NO (1) | NO141989C (sv) |
| PL (1) | PL103734B1 (sv) |
| SE (1) | SE440647B (sv) |
| SU (1) | SU648080A3 (sv) |
| YU (1) | YU40813B (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA009646B1 (ru) * | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
| AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH569692A5 (sv) | 1971-03-17 | 1975-11-28 | Richter Gedeon Vegyeszet | |
| US4067904A (en) * | 1975-12-19 | 1978-01-10 | Mead Johnson & Company | Alkylsulfonylphenoxypropanolamine derivatives |
-
1976
- 1976-03-02 HU HU76GO00001331A patent/HU172137B/hu not_active IP Right Cessation
-
1977
- 1977-02-25 CH CH235877A patent/CH627732A5/de unknown
- 1977-02-28 AT AT134177A patent/AT348507B/de not_active IP Right Cessation
- 1977-03-01 CA CA272,912A patent/CA1091254A/en not_active Expired
- 1977-03-01 CS CS771363A patent/CS190340B2/cs unknown
- 1977-03-01 FI FI770651A patent/FI65231C/fi not_active IP Right Cessation
- 1977-03-01 NO NO770688A patent/NO141989C/no unknown
- 1977-03-01 NL NL7702170A patent/NL7702170A/xx not_active Application Discontinuation
- 1977-03-01 DD DD7700197617A patent/DD128610A5/xx unknown
- 1977-03-01 AU AU22795/77A patent/AU508766B2/en not_active Expired
- 1977-03-01 SE SE7702251A patent/SE440647B/sv not_active IP Right Cessation
- 1977-03-01 GB GB8593/77A patent/GB1573191A/en not_active Expired
- 1977-03-01 PL PL1977196357A patent/PL103734B1/pl unknown
- 1977-03-01 BE BE1007979A patent/BE851938A/xx not_active IP Right Cessation
- 1977-03-01 DK DK88577A patent/DK143554C/da not_active IP Right Cessation
- 1977-03-01 SU SU772457128A patent/SU648080A3/ru active
- 1977-03-01 YU YU549/77A patent/YU40813B/xx unknown
- 1977-03-01 FR FR7705898A patent/FR2342956A1/fr active Granted
- 1977-03-01 IN IN292/CAL/77A patent/IN144243B/en unknown
- 1977-03-01 IL IL51574A patent/IL51574A/xx unknown
- 1977-03-02 JP JP52021640A patent/JPS5923299B2/ja not_active Expired
- 1977-03-02 DE DE2709109A patent/DE2709109C3/de not_active Expired
-
1979
- 1979-09-04 US US06/072,295 patent/US4310549A/en not_active Expired - Lifetime
-
1983
- 1983-10-24 KE KE3340A patent/KE3340A/xx unknown
-
1985
- 1985-12-30 MY MY104/85A patent/MY8500104A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8419266A0 (it) | Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori. | |
| NO152215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler | |
| ES482097A1 (es) | Procedimiento para preparar derivados acilicos de carnitina. | |
| AU557590B2 (en) | Aroylimidazolones | |
| MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
| NO155289C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. | |
| SE7702251L (sv) | Sett att framstella 1-tert-butylamino-3-(2,5-diklorfenoxi)-2-propanol | |
| NO145841C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3-substituerte, 5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning | |
| NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
| DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
| JPS5686194A (en) | Novel protein and its manufacture | |
| DK30581A (da) | Fremgangsmaade til fremstilling af 5-aminotetrazolderivater af retinsyrer | |
| SE7603223L (sv) | 13,14-dehydro-11-deoxi-prostaglandiner och forfarande for deras framstellning | |
| DE3378979D1 (en) | 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents | |
| GR80638B (en) | Method for the preparation of 2-tolyl-morpholine derivatives and their therapeutical use | |
| ES481109A1 (es) | Un metodo de preparacion de un extracto de stephania cepha- rantha. | |
| GR75239B (sv) | ||
| JPS5211086A (en) | Surface trimming equipment for steel | |
| GB1527479A (en) | Acid addition salts of d-(+)-1-(3-hydroxyphenyl)-2-aminopropane and their manufacture and use | |
| IT8024862A0 (it) | L'applicazione in terapeutica come agenti analgesici dei derivati del 4,5,6,7-tetraidroisossazolo (5,4-c)piridin-3-ol | |
| AU7196987A (en) | 1,4-dihydropyridine derivatives, process for their preparation and medicaments containing these compounds | |
| SE7806469L (sv) | Antihypertensiva kompositioner | |
| SE8201308D0 (sv) | Alkylendiaminderivat och forfarande for framstellning derav | |
| ES466627A1 (es) | Procedimiento para la obtencion de derivados amino del 4-hi-droxi-1,2-benzisotiazol | |
| ATA134577A (de) | Verfahren zur herstellung von 9,10- dihydroergosin und dessen physiologisch bertraeglichen saeureadditionssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 7702251-5 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 7702251-5 Format of ref document f/p: F |